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regulatory protein (Star) gene [30] , which encodes a cholesterol transporter essential for testosterone synthesis.
Despite the acknowledged role of COUP-TFII in the differentiation and function of the adult Leydig cell population, our understanding of its direct target genes, and therefore its mechanism of action in these cells, remains incomplete. In the current study, we report that the Amhr2 promoter is a novel target for COUP-TFII in MA-10 Leydig cells. COUP-TFII directly activates Amhr2 gene expression via a COUP-TFII-responsive, GC-rich sequence, present in the proximal Amhr2 promoter region, and that this transcriptional regulation involves a cooperation between COUP-TFII and specificity protein (SP)1. Importantly, these findings provide new insights not only into the mechanism of COUP-TFII action in adult Leydig cells but also help to better clarify Amhr2 transcription in these cells.
Materials and Methods

A. Plasmids
The 21486/177, 2758/177, 2486/177, 2257/177, 2151/177, 2122/177, 267/177, 251/ 177, 245/177, and 234/177 bp mouse Amhr2 promoter constructs were generated by PCR using an Amhr2 reporter construct as template provided by Dr. Jose Teixeira (Michigan State University, East Lansing, MI) and sequence-specific forward primers containing a BamHI cloning site and a common reverse primer containing a XhoI cloning site. The primer sequences are listed in Table 1 . PCR fragments were enzyme digested, gel purified, and cloned into the BamHI/SalI sites of a modified pXP1 luciferase reporter vector [40] . Mutations within the promoter region were generated using the PfuUltra High-Fidelity DNA Polymerase AD according to the manufacturer's instructions (Agilent Technologies, Santa Clara, CA) with the primer sets listed in Table 1 . A plasmid containing the mouse COUP-TFII cDNA [31] was obtained from Dr. Ming Tsai (Baylor College of Medicine, Houston, TX) and the COUP-TFII cDNA was subsequently subcloned into the pcDNA3.1 mammalian expression vector (Invitrogen Canada, Burlington, ON, Canada). All generated plasmids and PCR products were verified by an on-site sequencing service.
B. Cell Culture, Transfections, and Reporter Assays
Mouse MA-10 Leydig cells (American Type Culture Collection, Manassas, VA, catalog no. CRL-3050, RRID:CVCL_D789) [41], provided by Dr. Mario Ascoli (University of Iowa, Iowa City, IA), were grown in DMEM/F12 medium supplemented with 2.438 g/L sodium bicarbonate, 3.57 g/L HEPES, and 15% horse serum on plates coated with 0.1% gelatin. Penicillin and streptomycin sulfate were added to a final concentration of 50 mg/L, and cells were incubated at 37°C and 5% CO 2 in a humidified incubator. MA-10 Leydig cells were isolated from mouse Leydig cell tumors (M5480P), and they represent an immature Leydig cell population [42] as characterized by the high expression of 5a-reductase [43] . Stimulation of MA-10 Leydig cells by LH/human chorionic gonadotropin, forskolin, and cAMP results in increased steroid production [42] . MA-10 cells were transiently transfected using polyethylenimine hydrochloride (Sigma-Aldrich Canada, Oakville, ON, Canada) as described in Longo et al. [44] with minor modifications. Briefly, the cells were plated in 24-well plates 24 hours prior to the transfection. To determine COUP-TFII responsiveness, the cells were cotransfected on the next day with 400 ng of reporter vector along with different amounts of expression vectors and polyethylenimine dissolved in Opti-MEM medium (GIBCO by Life Technologies, Burlington, ON, Canada). To determine relative promoter activity, the cells were cotransfected with 400 ng of reporter vector, 10 ng of phRL-TK Renilla luciferase expression vector, and 90 ng of an inert pSP64 plasmid (Promega, Madison, WI). Sixteen hours after transfection, the media were replaced and the cells were grown for an additional 32 hours. After the cells were lysed, the cell lysates were collected and analyzed using Tecan Spark 10M multimode plate reader (Tecan, Morrisville, NC) as previously described [45, 46] . C. Small Interfering RNA Transfection and Reverse Transcription-Quantitative PCR MA-10 Leydig cells were transfected with 150 nM small interfering RNA (siRNA) directed against Coup-tfii transcripts (Nr2f2-MSS235957, Life Technologies, Carlsbad, CA) or with Stealth RNAi™ siRNA Negative Control, Med GC (Thermo Fisher Scientific, Mississauga, ON, Canada) using JetPRIME transfection reagent (PolyPlus-transfection, Illkirch, France) according to the manufacturer's protocol. The cells were incubated for 48 hours and total RNA was extracted using TRIzol (Thermo Fisher Scientific) following the supplier's instructions. Amhr2 mRNA levels were determined by reverse transcription-quantitative PCR (qPCR) as previously described [24, 45] . Relative expression of Amhr2 was normalized to the expression of Rpl19, used as internal control, and is plotted as a ratio of Amhr2 to Rpl19 levels; primer sets are listed in Table 1 .
D. Protein Purification and Western Blots
Nuclear proteins from MA-10 Leydig cells were extracted as previously described [47] and quantified using a Bradford protein assay (Bio-Rad Laboratories, Mississauga, ON, Canada). In vitro translated COUP-TFII was generated using the Promega TnT quick coupled transcription/translation system (Thermo Fisher Scientific) according to the manufacturer's protocol without additional purification or quantification. Denatured proteins were resolved by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane (Millipore, Etobicoke, ON, Canada). Immunodetection was performed using horseradish peroxidaseconjugated antibodies according to the manufacturers' protocols and the following reagents: ECL and ECL Prime Western blotting detection reagents (GE Healthcare Life Sciences, Mississauga, ON, Canada), Clarity Western ECL substrate (Bio-Rad Laboratories), Clarity Max Western ECL substrate (Bio-Rad Laboratories). Detection of COUP-TFII and lamin B proteins was performed using a mouse monoclonal anti-COUP-TFII antibody (dilution 1: 1000; R&D Systems, Minneapolis, MN; catalog no. PP-H7147-00, RRID:AB_2155627) [48] and a goat polyclonal anti-lamin B antibody (dilution 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. sc-6216, RRID:AB_648156) [49], respectively.
E. Chromatin Immunoprecipitation-qPCR Assay
Three million MA-10 Leydig cells were plated on a 0.1% gelatin-coated 100-mm plate and incubated for 24 hours. Once the cells reached 80% confluency, the protein/DNA complexes were crosslinked by supplementing the media with 1% formaldehyde and incubating for 10 minutes at 37°C. The crosslinking reaction was stopped by the addition of glycine to a final concentration of 125 mM with shaking for 10 minutes at 25°C. Chromatin immunoprecipitation (ChIP) experiments were performed as described previously [30] . ChIP DNA fragments were analyzed by qPCR using specific primer sets for proximal and distal regions of the Amhr2 gene regulatory region ( Table 1 ). The qPCR amplifications were done on a C1000 thermal cycler (Bio-Rad Laboratories) using PerfeCTa SYBR Green FastMix (Quantabio, Beverly, MA) and the following conditions: 3 minutes at 95°C, followed by 46 cycles of denaturation (10 seconds at 95°C), annealing (30 seconds at 59°C), and extension (20 seconds at 72°C). Specificity of the primer sets for the target regions were verified by agarose gel electrophoresis and sequencing. Results are represented as fold enrichments and were calculated from ChIP anti-COUP-TFII (R&D Systems, Minneapolis, MN; catalog no. PP-H7147-00, RRID:AB_2155627) [48] samples relative to the ChIP control IgG (Santa Cruz Biotechnology; catalog no. sc-2025, RRID:AB_737182) [50] after both samples were normalized to the input. Fold enrichment was calculated as follows: fold enrichment 5 2 2DDCt , where each target gene region was first normalized to the input following the formula "normalized to input" DCt 5 DCt (ChIP) 2 (DCt inputlog dilution factor). Then, 2DDCt 5 normalized to input DCt (NR2F2) 2 normalized to input DCt (IgG). The ChIP results were confirmed in three separate experiments. 
F. DNA Pulldown Assay
DNA pulldown assays were performed as previously described [30] with minor modifications. Biotinylated and nonbiotinylated oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, IA) and are listed in Table 1 . Ten micrograms of biotinylated oligonucleotides and 10 mg of complementary oligonucleotides were annealed in 100 mL of Taq reaction buffer (New England Biolabs, Whitby, ON, Canada) using a Biometra T Gradient thermocycler (Montréal Biotech, Dorval, QC, Canada) and stored at 220°C until use. Streptavidin magnetic beads from Promega (Thermo Fisher Scientific) were washed four times with B&W buffer [5 mM Tris-Cl (pH 7.5), 0.5 mM EDTA, and 1 M NaCl]. DNA probes were diluted to 20 ng/mL in B&W buffer. One microgram of the diluted DNA probe was added to 50 mL of prewashed magnetic beads and incubated at 24°C for 20 minutes. The beads were washed once with 300 mL of cold B&W buffer, once with 300 mL of protein binding buffer [20 mM Tris-Cl (pH 7.5), 1 mM EDTA, 1 mM dithiothreitol, 0.15% Triton X-100, 100 mM NaCl, 4 mM MgCl 2 , 5% glycerol]. After DNA probes were bound to the beads, the beads were blocked with 0.67% BSA in 300 mL of protein binding buffer by rotation at 23°C for 20 minutes. Next, the beads were washed once with protein binding buffer. To the beads, 130 mg of nuclear extract was added in 500 mL of protein binding buffer and incubated for 90 minutes (60 minutes at 4°C and 30 minutes at 23°C) with constant rotation, followed by seven washes in 300 mL of cold protein binding buffer. Bound proteins were eluted in 20 mL of 13 Laemmli buffer by incubating at 95°C for 10 minutes and analyzed by Western blotting.
G. Statistical Analyses
All statistical analyses were performed using GraphPad Prism software (GraphPad Software, San Diego, CA; RRID:SCR_002798) [51] or Microsoft Excel (Microsoft Corporation, Redmond, WA; RRID:SCR_016137) [52] . Statistical analyses between two groups were performed using a Student t test or by one-way ANOVA followed by a Newman-Keuls post hoc test for multiple comparisons between the groups. P values from each comparison are indicated in the figure legends.
Results
A. COUP-TFII Regulates Amhr2 Gene Transcription in Leydig Cells
Transcriptomic microarray analysis of COUP-TFII-depleted MA-10 Leydig cells revealed several genes whose expression was affected by the lower level of COUP-TFII protein (data not shown). Owing to its well-established role in Leydig cell differentiation and steroidogenesis [6, 7, 11, 53] , an interesting candidate was the Amhr2 gene. We therefore decided to further investigate whether COUP-TFII could be involved in the regulation of Amhr2 gene expression. MA-10 Leydig cells were transfected with either control siRNA or siRNA directed against COUP-TFII. Decreased COUP-TFII protein levels were confirmed by Western blot (Fig. 1A, top panel) . In COUP-TFII-depleted MA-10 Leydig cells, Amhr2 mRNA levels were reduced by ;36% compared with control cells (Fig. 1A , bottom panel). To test whether the decrease in Amhr2 mRNA levels in COUP-TFII-depleted cells was due to a direct action of COUP-TFII on the Amhr2 promoter, MA-10 Leydig cells were cotransfected with two mouse Amhr2 reporter constructs, 21486/177 bp and 234/177 bp, in the absence or presence of a COUP-TFII expression vector. As shown in Fig. 1B , the 21486/177 bp Amhr2 reporter was activated up to fourfold by COUP-TFII, whereas the 234/177 bp Amhr2 reporter was only weakly activated by COUP-TFII.
B. COUP-TFII-Dependent Activation of the Amhr2 Promoter Does Not Require SF1 Regulatory Elements
Previous studies have demonstrated that COUP-TFII can act via SF1 regulatory elements on target genes [54] [55] [56] . The Amhr2 promoter contains two previously characterized SF1 elements at 2250 bp (5 0 -AGGTCA-3 0 ) and at 2200 bp (5 0 -AGGTCC-3 0 ) [17] . To test whether COUP-TFII regulates Amhr2 promoter activity through the two SF1 elements, Ahmr2 promoter constructs harboring mutations in the distal, proximal, or both SF1 elements were generated and transfected in MA-10 Leydig cells. Surprisingly, these mutations had no impact on COUP-TFII responsiveness (Fig. 2) , which suggests that one or more unknown regulatory elements are required. C. An Intact GC-Rich Sequence Is Essential for COUP-TFII-Dependent Activation of the Amhr2 Promoter
To locate the COUP-TFII response element, a series of 5 0 progressive deletion constructs were generated and transfected in MA-10 Leydig cells. As shown in Fig. 3A , deletion from 21486 to 267 bp did not impair COUP-TFII-dependent activation of the Amhr2 promoter. However, a 234 bp deletion construct was only modestly activated by COUP-TFII (2-fold compared with ;20-fold with longer promoter constructs) ( Fig. 3A) . These results suggest that the critical COUP-TFII response element is located between 267 and 234 bp. Analysis of the basal promoter activity of the same Amhr2 deletion constructs revealed a small but significant increase in activity with deletion from 21486 bp to 2486 bp ( Fig. 3B ). Subsequent deletions to 2122 bp and 267 bp caused a significant decrease in promoter activity ( Fig. 3B) , with the 267 bp reporter having only ;30% activity of the 21486 bp reporter. Finally, a deletion to 234 bp abrogated Amhr2 promoter activity (Fig. 3B ). These data indicate that the key regulatory elements required for Amhr2 promoter activity in MA-10 Leydig cells are located within 2122 to 234 bp, the region that also contains the COUP-TFII response element.
We next determined whether COUP-TFII could directly bind to the 267/234 bp region of the Amhr2 promoter. Using DNA pulldown assays and nuclear extracts from MA-10 Leydig cells, we found that COUP-TFII binds in vitro to oligonucleotides corresponding to the 267/234 bp region (Fig. 4A, lane 4) , as well as to a high-affinity direct repeat 1 (DR1) binding sequence used as positive control (Fig. 4A, lane 2) . No significant binding was observed when only the magnetic beads were used as a negative control (Fig. 4A, lane 3) . We subsequently performed ChIP-qPCR to determine whether COUP-TFII is recruited to the 267/234 bp region of the Amhr2 promoter in a native chromatin environment in MA-10 Leydig cells. As shown in Fig. 4B , COUP-TFII was found to be associated with the proximal Amhr2 promoter, between 2140 and 129 bp, a region that contains the 267/234 bp COUP-TFII-responsive sequence. In contrast, COUP-TFII was not significantly recruited to a distal region of the Amhr2 gene (23395 to 23274 bp) that is devoid of AGGTCA-like motifs and was used as negative control.
To better locate the COUP-TFII binding region, we performed an in silico analysis of the 267/234 bp region of the Amhr2 promoter across different species. This analysis revealed the presence of a potential nuclear receptor element (NRE) 5 0 -AGGACA-3 0 (Fig. 5A ) at 248 bp that could potentially be recognized by COUP-TFII. To test the functional importance of this predicted nuclear receptor motif in COUP-TFII responsiveness, we used site-directed mutagenesis to mutate the NRE sequence (AGGACA to AaagCA, M1) in the context of the 267/ 177 bp Amhr2 promoter. Surprisingly, mutation of the NRE did not significantly impair the ability of COUP-TFII to activate the Amhr2 reporter ( Fig. 5B ), suggesting that the 5 0 -AGGACA-3 0 motif is not responsible for the COUP-TFII responsiveness. In agreement with this observation, we found that COUP-TFII present in nuclear extracts could still bind to the mutated 267/234 bp sequence in DNA pulldown assays (Fig. 5C, lane 4) . To ultimately pinpoint the COUP-TFII response element within the 267/234 bp region of the Amhr2 promoter, we generated two additional 5 0 deletion constructs of the Amhr2 promoter: 251/177 bp (retains the NRE) and 245/177 bp (removes the NRE). As shown in Fig. 6 , both 251 bp and 245 bp reporters were still activated by COUP-TFII, although the 234 bp was no longer responsive. This indicated that the COUP-TFII response element most likely resides between 245 and 234 bp. Sequence analysis of the 245 to 234 bp region identified a GC-rich sequence (5 0 -GCGGGGCGG-3 0 ) at 243/234 bp that is adjacent to the NRE and well conserved across species (Fig. 7A) . To validate the requirement of this GC-rich sequence, different mutations were introduced within the 267/177 bp construct: GCGGGGCGG to GCttGGCGG (M2), GCGGGGCGG to GCGGGGCtt (M3), and GCGGGGCGG to GCttGGCtt (M4). Cotransfections in MA-10 Leydig cells showed that all three mutations reduced COUP-TFII-mediated activation to background levels, as observed with the minimal 234 bp reporter (Fig. 7B ). An intact GC-rich sequence at 239 bp is therefore essential for COUP-TFII-dependent activation of the Amhr2 promoter.
D. COUP-TFII Binds to the GC-Rich Sequence
To confirm whether COUP-TFII directly binds to the GC-rich sequence in vitro, we performed DNA pulldown assays using either nuclear extracts from MA-10 Leydig cells that endogenously express COUP-TFII (Fig. 8A) or recombinant COUP-TFII in vitro transcribed and translated (Fig. 8B ). As expected, endogenously expressed COUP-TFII was found to bind to oligonucleotides containing 267/234 bp wild-type (WT) and 267/234 bp M1 (mutated NRE) (Fig. 8A, lanes 5 and 7, respectively) . COUP-TFII from MA-10 nuclear extracts could still bind to oligonucleotides 267/234 bp M4 containing a mutated GC-rich sequence (above background observed with the beads), albeit to a lesser extent than the WT or M1 (mutated NRE) sequences (compare lanes 5, 6, and 7 in Fig. 8A) . The residual binding observed with M4 could be due to low-affinity binding of COUP-TFII to the NRE. We also found that COUP-TFII from MA-10 Leydig cell nuclear extracts can bind to oligonucleotides containing the SF1 distal (5 0 -AGGTCA-3 0 ) and SF1 proximal (5 0 -AGGTCC-3 0 ) sequences (Fig. 8A, lanes 8 and 9, respectively) of the Amhr2 promoter, with COUP-TFII having a higher affinity for the distal site. A high-affinity DR1 (HA-DR1) WT binding site was used as positive control (Fig. 8A, lane 2) , whereas magnetic beads (Fig. 8A, lane 4) and a mutated HA-DR1 sequence (Fig. 8A, lane 3) were used as negative controls. Because COUP-TFII can bind to DNA in association with other transcription factors present in nuclear extracts, we used in vitro transcribed/translated COUP-TFII in DNA pulldown assays to study the binding properties of the COUP-TFII protein by itself. As expected, in vitro-produced COUP-TFII could bind to the HA-DR1 sequence (Fig. 8B, top panel, lane 2) . COUP-TFII binding was also observed on the SF1 distal sequence (Fig. 8B, top panel, lane 7) . To detect any low-affinity binding of COUP-TFII, the same blot was exposed for a longer period (Fig.  8B, lower panel) . This longer exposure revealed that COUP-TFII can bind weakly to the SF1 proximal sequence (Fig. 8B, lower panel, lane 8) . Very weak binding of in vitro produced COUP-TFII to the WT 267/234 bp sequence was also detected (Fig. 8B , lower panel, lane 5). Mutation of the GC-rich sequence (M4) within the 267/234 bp sequence abolished the binding, as it was indistinguishable from the magnetic beads used as negative control (Fig.  8B, lower panel, lanes 4 and 6) . The weak binding of in vitro-generated COUP-TFII by itself to the 267/234 bp sequence of the Amhr2 promoter indicates that it likely requires the presence of another transcription factor present in MA-10 Leydig cell extracts to properly bind to this sequence.
E. COUP-TFII Cooperates With SP1 on the Amhr2
Promoter GC-rich sequences are known to be bound by members of the SP family of transcription factors, such as SP1 and SP3 (reviewed in [57] ). SP1 and SP3 are ubiquitously expressed, including in various Leydig cell lines such as MA-10 Leydig cells [58, 59] . Furthermore, SP1 and COUP-TF factors have been reported to cooperate to regulate gene expression (reviewed in [60] ). We therefore examined the possibility that COUP-TFII and SP1 might cooperate on the Amhr2 promoter. As shown in Fig. 9 , COUP-TFII can activate the Amhr2 promoter by ;10-fold whereas SP1 is a weaker activator (;1.6-fold). Combination of both transcription factors led to synergistic activation of 20-fold ( Fig. 9 ). This COUP-TFII/SP1 cooperation was Figure 8 . COUP-TFII binds to the 267/234 bp Amhr2 region. DNA pulldown assays were performed using either nuclear extracts from MA-10 Leydig cells (A) or in vitro-produced COUP-TFII (B) along with various biotinylated double-strand oligonucleotides containing a high-affinity COUP-TFII DR1 sequence WT (HA-DR1 WT) or harboring a mutation that destroys the binding site (HA-DR1 Mut), the Amhr2 267/234 bp sequence either WT or with a mutation in the potential NRE (M1) or in the GC-rich sequence (M4), or the previously characterized SF1 distal and proximal elements. Beads alone (no oligonucleotide) were used as a negative control (Beads). Input in (A) corresponds to 5 mg of the nuclear extracts, and in (B) to 2.5% (v/v) of the product of the in vitro translation reaction used in the DNA pulldown assay (n 5 3). Western blots were used to detect COUP-TFII. Input corresponds to 5 mg of the nuclear extracts used in the DNA pulldown assay (n 5 3). In (B), two images of the same blot using different exposure times are shown. lost when the GC-rich sequence was mutated (M4 in Fig. 9 ) and no cooperation was observed with the minimal 234/177 bp reporter ( Fig. 9 ).
Discussion
AMH is abundantly produced by Sertoli cells during fetal life to ensure regression of the Müllerian ducts in developing male embryos. AMH is also present in the adult testis, albeit at lower level, where it is known to regulate Leydig cell steroidogenesis [4, [6] [7] [8] [9] as well as postnatal Leydig cell differentiation [4, [8] [9] [10] [11] 61] . The effects of AMH on Leydig cells are mediated via the AMH receptors AMHR2 [4, 15] and ALK3 [19] . Leydig cell lines, including rat R2C and mouse MA-10, are known to express Amhr2, and treatment of these cells or mice with AMH represses steroidogenesis [6] [7] [8] [9] .
A. Identification of COUP-TFII as a New Regulator of Amhr2 Expression in Leydig Cells
Despite the importance of AMH/AMHR2 in regulating Leydig cell differentiation and function, very little is known about the regulation of Amhr2 gene expression in these cells. Studies on the human and rat AMHR2 promoter have revealed that the nuclear receptor SF1 (NR5A1/Ad4BP) is important for AMHR2 promoter activity [17, 22] .
The nuclear receptor COUP-TFII (NR2F2) is also expressed in Leydig cells from the adult population and is known to bind to DNA sequence similar to SF1 elements [54] [55] [56] 62] . As SF1, COUP-TFII regulates the expression of the Star [30] and Insl3 [63] genes in Leydig cells. Our analysis of COUP-TFII-depleted MA-10 Leydig cells revealed that Amhr2 mRNA levels were significantly reduced in the absence of COUP-TFII, indicating that COUP-TFII is also required for expression of the endogenous Amhr2 gene in these cells. Consistent with a direct action on Amhr2 transcription, we found that COUP-TFII could activate a 21486 bp mouse Amhr2 promoter construct in MA-10 Leydig cells. This promoter fragment contains the two previously characterized SF1 elements at 2250 bp (5 0 -AGGTCA-3 0 ) and at 2200 bp (5 0 -AGGTCC-3 0 ) to which COUP-TFII can bind in vitro. However, mutation/deletion of either or both SF1 elements had no effect on the transactivation of the Amhr2 promoter by COUP-TFII, indicating that they are not required for COUP-TFII-mediated activation. Although another region of the Amhr2 promoter is required for COUP-TFII responsiveness, it remains possible that COUP-TFII might still contribute to Amhr2 transcription via the SF1 elements in a different context.
Results from functional studies in R2C Leydig cells revealed that a sequence located between 299 and 291 bp of the Amhr2 promoter and containing an AGG core nuclear receptor binding motif (5 0 -AGAGGTGGGT-3 0 ) is required for maximal activation by SF1 [17] . We hypothesized that the same region might be involved in COUP-TFII-dependent transactivation of the Amhr2 promoter. However, we found that deletion of that region did not affect Amhr2 promoter activation by COUP-TFII in MA-10 Leydig cells. Instead, we found that a region between 267 and 234 bp, to which COUP-TFII can bind, is essential for COUP-TFII-dependent activation of mouse Amhr2 promoter in MA-10 Leydig cells. This is also consistent with the fact that the proximal Amhr2 promoter (2151 to 234 bp) contains all of the regulatory elements for maximal activity in MA-10 Leydig cells.
B. Mechanisms of COUP-TFII Action on the Amhr2 Promoter
Sequence analysis of the 267 to 234 bp region revealed the presence of a potential NRE that contains an AGG core motif for the binding of nuclear receptors (5 0 -AGGACA-3 0 ). We initially hypothesized that COUP-TFII might regulate Amhr2 promoter activity via this NRE. Surprisingly, deletion or mutation (5 0 -AGGACA-3 0 to AaagCA-3 0 ) of the NRE did not reduce COUP-TFII-dependent activation. Similarly, mutation of the NRE did not drastically affect the binding of COUP-TFII present in nuclear extracts from MA-10 Leydig cells. These data indicate that COUP-TFII either directly binds to another sequence within the 267 to 234 bp region or is recruited to the proximal promoter via interaction with another DNA-bound transcription factor. The reduced binding of in vitro-produced recombinant COUP-TFII compared with COUP-TFII present in nuclear extracts from MA-10 Leydig cells supports the hypothesis of an interaction with, or stabilization by, another transcription factor. This is also consistent with the fact that COUP-TFII is known to regulate gene expression as homodimer or heterodimer with other transcription factors (reviewed in [29, 64, 65] ).
Fine mapping of the Amhr2 promoter revealed that the COUP-TFII-responsive sequence is located between 245 and 234 bp. This sequence contains a species-conserved GC-rich sequence, and mutations within the GC-rich sequence abolished COUP-TFII-dependent activation of the Amhr2 promoter and reduced binding of COUP-TFII present in MA-10 Leydig cell extracts as well as in vitro-produced recombinant COUP-TFII, which indicates that COUP-TFII can bind directly to the GC-rich sequence, albeit with low affinity. Interestingly, footprinting analyses of the Amhr2 promoter incubated with nuclear proteins from R2C Leydig cells revealed that the GC-rich sequence is protected from DNase I digestion, which indicates the binding of a transcription factor thought to be SP1 [17] . SP1 belongs to a family of ubiquitous transcription factors that can drive gene expression by binding to GC-rich sequences located in promoter region of target genes (reviewed in [57] ). SP1 is expressed in Leydig cells where it regulates expression of several genes, including the genes encoding the LH receptor [66] , the nuclear receptor SF1 [67] , and the PDGF-Ra [58] .
Although the role of SP1 in Amhr2 expression in Leydig cells remained unexplored, it was proposed that it might participate in the initiation of transcription of this TATA-less promoter and/or interact with other transcription factors to contribute to the expression of the gene [17] . In agreement with this hypothesis, we found that COUP-TFII and SP1 functionally cooperate to further activate the Amhr2 promoter and that this activation required an intact GC-rich sequence. These data support a model ( Fig. 10) whereby COUP-TFII by itself can bind with low affinity to the GC-rich sequence within the proximal Amhr2 promoter ( Fig. 10A) and is stabilized by an interaction with SP1 and/or another transcription factor (Fig. 10B ), ultimately leading to increased Amhr2 gene transcription. In addition to the GC-rich sequence, we cannot exclude the possibility that the NRE is also involved in COUP-TFII binding to the Amhr2 promoter once SP1 has stabilized the complex. However, in our experiments, we consistently observed a significant decrease in COUP-TFII-dependent activation when the GC-rich sequence is mutated, indicating that the NRE sequence cannot compensate for the absence of an intact adjacent GC-rich sequence. A similar mechanism of COUP-TFII recruitment via DNA-bound SP1 was originally proposed by Pipaón et al. [68] to describe COUP-TFII action on the nerve growth factor-induced protein A (Ngfi-A/Egr-1) promoter. In their model, they proposed that SP1 serves as a docking protein for COUP-TF, as they found that COUP-TF cannot bind its responsive element alone. Since then, this mechanism of SP1/COUP-TF cooperation has been reported for the expression of several other genes in various tissues, including the human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR) [69] , neuropilin 2 (Nrp2) [70] , orthodenticle homeobox 2 (Otx2) [71] , EYA transcriptional coactivator and phosphatase 1 (Eya1), Wilms' tumor 1 (Wt1) [72] , E2F transcription factor 1 (E2f1) [73] , angiopoietin 1 (Ang1) [74] , Glut4 [75] , and IGF-1 (Igf1) [76] . These gene promoters, although activated by COUP-TFII, do not contain a classical COUP-TFII binding site. COUP-TFII responsiveness was rather found to require an intact SP1 element in the proximal promoter to which COUP-TFII is recruited. However, recruitment of COUP-TFII to those GC-rich sequences had so far only been demonstrated by ChIP, which does not discriminate between direct binding to DNA and indirect recruitment via interaction with another DNA-bound transcription factor. Our current work shows that COUP-TFII can directly bind to a GC-rich sequence. In addition to a functional cooperation, COUP-TFII and SP1 were found to physically interact [68] , consistent with an SP1-mediated recruitment and/or stabilization of COUP-TFII to the promoter of target genes.
In conclusion, our present work establishes a role for the nuclear receptor COUP-TFII in the expression of the Amhr2 gene in Leydig cells. We found that COUP-TFII action does not require direct binding to DNA but rather involves a cooperation with the SP1 transcription factor bound to a GC-rich sequence within the proximal Amhr2 promoter. 
